Parkinson’s disease Archives

Home / Posts tagged Parkinson’s disease

CereSpir Incorporated and the National Neuroscience Institute Singapore Announce Positive Data Showing Beneficial Effects of CereSpir’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

NEW YORK and SINGAPORE, Dec. 10 (Korea Bizwire) — CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research [...]

Parkinson’s Patients are Most Prone to Suicide: Survey

SEOUL, Mar. 19 (Korea Bizwire) — People suffering from Parkinson’s disease and depression are the most susceptible to committing suicide, a survey showed Monday. Parkinson’s disease patients have 4.72 times higher chances of committing suicide than those who do not have the disease, according to the survey of 300,232 people conducted by professor Kim Doh-kwan [...]

Taconic Biosciences Announces Release of New Parkinson’s Disease Animal Model

HUDSON, N.Y., Apr. 25 (Korea Bizwire) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective April 17, 2017, in conjunction with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), began commercial distribution of a new Parkinson’s disease mouse Model 13940 (C57BL/6- Lrrk2tm4.1Arte). The development of Model [...]

Air Pollution Aggravates Parkinson’s Disease: Study

SEOUL, March 24 (Korea Bizwire) – Exposure to air pollution increases risk of aggravating Parkinson’s disease and may cause neurological disease progression, a study showed Friday. According to the study by Kim Ho at Seoul National University, patients with the neurodegenerative disease are more likely to visit emergency rooms during days with high levels of [...]

Pharmaceutical Companies Race to Develop New Parkinson’s Drugs

SEOUL, Oct. 25 (Korea Bizwire) – Korean pharmaceutical companies are making significant developments in their research of Parkinson’s disease. Parkinson’s is often associated with the elderly, making Korea’s rapidly-aging society more vulnerable to the disease, for which there is no cure. Dong-A ST is set to apply for a phase 2 clinical trial for the [...]

Korean Medical Firm to Acquire Danish Bio-venture Contera Pharma

SEOUL, Sept. 24 (Korea Bizwire) – Bukwang Pharmaceutical, famous for anemia medicine Feroba, is expected to acquire Danish bio-venture firm Contera Pharma, which developed a new treatment material for Parkinson’s disease. After the acquisition, the Korean medical company will focus on the development of medicine for the disease. On September 23, Bukwang announced that it [...]